Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
66,342,236
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
38,578,679
-
Shares change
-
+4,563,410
-
Total reported value, excl. options
-
$221,831,767
-
Value change
-
+$26,597,543
-
Put/Call ratio
-
100%
-
Number of buys
-
67
-
Number of sells
-
-37
-
Price
-
$5.75
Significant Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q2 2024
122 filings reported holding BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share as of Q2 2024.
Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,578,679 shares
of 66,342,236 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (13,021,324 shares), Juniper Investment Company, LLC (6,833,857 shares), Nantahala Capital Management, LLC (5,338,314 shares), BlackRock Inc. (2,371,381 shares), VANGUARD GROUP INC (1,660,666 shares), GEODE CAPITAL MANAGEMENT, LLC (875,122 shares), MILLENNIUM MANAGEMENT LLC (550,035 shares), CITADEL ADVISORS LLC (542,763 shares), MORGAN STANLEY (523,441 shares), and RENAISSANCE TECHNOLOGIES LLC (503,175 shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.